Author:
RATHORE MANOJ KUMAR,MOHAN REDDY T. RAMA
Abstract
Objective: This study aimed to develop a highly sensitive method for the determination of the genotoxic impurity 2-amino pyridine in Tenoxicam, employing hyphenated techniques.
Methods: The determination of 2-amino pyridine was carried out using a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method in Selected Ion Monitoring mode (SIM). A LiChrospher RP-18 (100×4.6 mm) 5.0 µm column was utilized for the separation. A gradient elution technique was employed with acetonitrile (mobile phase A) and 0.01M ammonium acetate buffer (mobile phase B) in varying ratios. The gradient program (T/%B) was set as 0/5, 2.50/15, 5.00/30, 10.00/50, 15.00/95, 20.00/95. The developed method was validated according to the International Conference on Harmonization guidelines.
Results: The limits of detection (LOD) and quantification (LOQ) for 2-amino pyridine were found to be 0.09 ppm and 0.3 ppm, respectively. The method demonstrated accuracy within the range of 89.1% to 106.6% for the analyte. The method's linearity was confirmed through a six-point calibration graph spanning 6 ppm to 75 ppm, corresponding to a concentration of 20 mg/ml of Tenoxicam.
Conclusion: Developed hyphenated LC-MS/MS method presented in this study offers a highly sensitive and accurate means for the determination of the genotoxic impurity 2-amino pyridine in Tenoxicam. With validated LOD and LOQ values, as well as demonstrated accuracy, this method proves to be a robust quality control tool suitable for the quantitation of 2-amino pyridine at very low concentrations in the pharmaceutical compound Tenoxicam.
Publisher
Innovare Academic Sciences Pvt Ltd
Reference19 articles.
1. Madni MA, Raza A, Abbas S, Tahir N, Rehman M, Kashif PM. Determination of tenoxicam in the plasma by reverse phase HPLC method using single step extraction technique: a reliable and cost effective approach. Acta Pol Pharm. 2016 Sep;73(5):1123-8. PMID 29638052.
2. Abdel Hamid ME. LC-MS analysis of selected sulfur-containing non-steroid anti-inflammatory agents: applications to pharmaceutical products. J Liq Chromatogr Relat Technol. 2000;23(20):3095-107. doi: 10.1081/JLC-100102370.
3. AMIN AS. Spectrophotometric determination of piroxicam and tenoxicam in pharmaceutical formulations using alizarin. J Pharm Biomed Anal. 2002;29(4):729-36. doi: 10.1016/s0731-7085(02)00035-3, PMID 12093502.
4. Ji HY, Lee HW, Kim YH, Jeong DW, Lee HS. Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry. J Chromatogr B. 2005;826(1-2):214-9. doi: 10.1016/j.jchromb.2005.08.023.
5. Raghavan CV, Abimon VD. Intranasal delivery of tenoxicam in rat. Int J Pharm. 2001;221(1-2):227-9. doi: 10.1016/s0378-5173(01)00635-4, PMID 11397584.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献